Media ReleasesBARD1 Life Sciences

View All BARD1 Life Sciences News

BARD1 Life Sciences - Notice required under listing rule 3.13.1

BARD1 Life Sciences Limited (ASX:BD1) (BARD1 or the Company), advises that the Annual General Meeting is currently scheduled for 29 November 2021. The closing date for the receipt of nominations from persons wishing to be considered for election as a director of the Company is 18 October 2021. Any nominations must be received in writing no later than 5.00pm (AEDT) on 18 October 2021 at the Company’s registered office.

Shareholders will be advised of further details regarding the AGM in a separate Notice of Meeting which will be provided in due course. 

For more information, download the attached PDF.

Download this document

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.